Verseon (LSE:VERS) Scaled Net Operating Assets : 0.87 (As of Jun. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Verseon Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Verseon's operating assets for the quarter that ended in Jun. 2019 was £43.67 Mil. Verseon's operating liabilities for the quarter that ended in Jun. 2019 was £4.78 Mil. Verseon's Total Assets for the quarter that ended in Dec. 2018 was £44.52 Mil. Therefore, Verseon's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2019 was 0.87.

Verseon Scaled Net Operating Assets Historical Data

The historical data trend for Verseon's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Scaled Net Operating Assets Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Scaled Net Operating Assets

Get a 7-Day Free Trial

-21.16

76.55

0.25

0.48

0.95

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
Scaled Net Operating Assets	Get a 7-Day Free Trial									0.36	0.57	0.80	0.74	0.87

Competitive Comparison of Verseon's Scaled Net Operating Assets

For the Biotechnology subindustry, Verseon's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verseon's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verseon's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Verseon's Scaled Net Operating Assets falls into.

Verseon Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Verseon's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2018 )
=	(Operating Assets (A: Dec. 2018 )	-	Operating Liabilities (A: Dec. 2018 ))	/	Total Assets (A: Dec. 2017 )
=	(41.646	-	3.433)	/	40.4
=	0.95

where

	Operating Assets		(A: Dec. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	44.524	-	2.878
=	41.646

	Operating Liabilities		(A: Dec. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	24.619	-	20.891	-	0.295
=	3.433

Verseon's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2019 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2019 )
=	(Operating Assets (Q: Jun. 2019 )	-	Operating Liabilities (Q: Jun. 2019 ))	/	Total Assets (Q: Dec. 2018 )
=	(43.673	-	4.78)	/	44.524
=	0.87

where

	Operating Assets		(Q: Jun. 2019 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	45.459	-	1.786
=	43.673

	Operating Liabilities		(Q: Jun. 2019 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	26.542	-	21.462	-	0.3
=	4.78

Verseon Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Verseon's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (LSE:VERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.